E2F7 and nasopharyngeal carcinoma: These findings demonstrated that the VIRMA-E2F7 axis promotes NPC proliferation and metastasis by upregulating ITGA2, ITGA5, and NTRK1 expression, which subsequently activates the PI3K/Akt pathway (Fig. 8).